Answer
Yes, the Aurobindo Pharma - Milpharm Ltd. doxazosin 8 mg tablet product should be administered with caution in patients with evidence of impaired liver function, as doxazosin is wholly metabolised by the liver and data in liver impairment are limited.
Sources for this answer
- Doxazosin 8mg tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked